[1. Albright F. A page out of the history of hyperparathyroidism. J Clin Endocrinol Metab 1948; 8(8): 637-57.10.1210/jcem-8-8-637]Search in Google Scholar
[2. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99(10): 3561-3569.10.1210/jc.2014-1413]Search in Google Scholar
[3. Clark BL. Asymptomatic Primary Hyperparathyroidism. – In: Brandi ML (ed): Parathyroid Disorders. Focusing on Unmet Needs. Front Horm Res. Basel, Karger, 2019, vol 51, 13-22.10.1159/000491035]Search in Google Scholar
[4. Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom 2013; 16(1): 33-39.10.1016/j.jocd.2012.12.001]Search in Google Scholar
[5. Kanis JA, Cooper C, Rizzoli R, Reginster JY. Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2019; 30(1): 3-44.10.1007/s00198-018-4704-5]Search in Google Scholar
[6. Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab 2018; 103(11): 3993-4004.10.1210/jc.2018-01225]Search in Google Scholar
[7. Itani M, Middleton WD. Parathyroid Imaging. Radiol Clin North Am 2020; 58(6): 1071-1083.10.1016/j.rcl.2020.07.006]Search in Google Scholar
[8. Silva BC, Cusano NE, Bilezikian JP. Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 2018; 32(5): 593-607.10.1016/j.beem.2018.09.004]Search in Google Scholar
[9. Macfarlane DP, Yu N, Leese GP. Subclinical and asymptomatic parathyroid disease: implications of emerging data. Lancet Diabetes Endocrinol 2013 1(4): 329-340.10.1016/S2213-8587(13)70083-4]Search in Google Scholar
[10. Borissova A-M, Vlahov JD, Krivoshiev SG, et al. The prevalence of hyperparathyroidism in the Bulgarian population – Analysis of an epidemiological study by the Bulgarian Society of Endocrinology (BSE) – 2012. J Endocrinologia 2019; 24(4): 202-212.]Search in Google Scholar
[11. Souberbielle JC, Cavalier E, Cormier C. How to manage an isolated elevated PTH? Ann Endocrinol (Paris) 2015; 76(2): 134-41.]Search in Google Scholar
[12. Borissova AM, Shinkov A, Vlahov J, et al. Prevalence of vitamin D deficiency, insufficiency and sufficiency in Bulgarian population aged 20-80 years. Endocrinologia 2012; 17(3):122-134.]Search in Google Scholar
[13. Borissova AM, Rashkov R, Boyanov M, et al. Femoral neck bone mineral density and 10-year absolute fracture risk in a national representative sample of Bulgarian women aged 50 years and older. Arch Osteoporos 2011; 6: 189-95.10.1007/s11657-011-0064-x22886105]Search in Google Scholar
[14. Borissova AM, Kovatcheva R, Ivanova RB, et al. Hyperparathyroidism – a 7-year retrospective analysis at the specialized Clinic of Thyroid and Disorders of the Bone Mineral Metabolism. Endocrinologia 2004; 9(1): 33-42.]Search in Google Scholar
[15. Lafferty FW. Differential diagnosis of hypercalcemia. J Bone Miner Res 1991; 6(Suppl. 2): S51-9; discussion S61.10.1002/jbmr.56500614131763670]Search in Google Scholar
[16. Babwah F, Buch HN. Normocalcaemic primary hyperparathyroidism: a pragmatic approach. J Clin Pathol 2018; 71(4): 291-297.10.1136/jclinpath-2017-20445529437827]Search in Google Scholar
[17. Abusahmin H, Geen J, Das G. Subclinical urolithiasis in patients with asymptomatic primary hyperparathyroidism. Ther Adv Endocrinol Metab 2018; 9(11): 325-327.10.1177/2042018818788201619492930349660]Search in Google Scholar
[18. Burckhardt P. Lithiase rénale dans le cadre de l’hypercalciurie idiopathique et de l’hyperparathyroïdie primitive [Renal lithiasis in idiopathic hypercalciuria and primary hyperparathyroidism]. Ann Med Interne (Paris) 1986; 137(3): 216-9.]Search in Google Scholar
[19. Miller A, Mitchell JP. Hyperparathyroidism and renal calculi. Br J Urol 1952; 24(2): 91-8.10.1111/j.1464-410X.1952.tb04666.x]Search in Google Scholar
[20. Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab 2011; 96(8): 2377-85.10.1210/jc.2011-056921646371]Search in Google Scholar
[21. Selberherr A, Hörmann M, Prager G et al. “Silent” kidney stones in “asymptomatic” primary hyperparathyroidism-a comparison of multidetector computed tomography and ultrasound. Langenbecks Arch Surg 2017; 402(2): 289-293.10.1007/s00423-016-1520-2534642727734157]Search in Google Scholar
[22. Wood K, Dhital S, Chen H, Sippel RS. What is the utility of distal forearm DXA in primary hyperparathyroidism? Oncologist 2012; 17(3): 322-325.]Search in Google Scholar
[23. Scattergood S, Marsden M, Kyrimi E et al. Combined ultrasound and Sestamibi scintigraphy provides accurate preoperative localization for patients with primary hyperparathyroidism. Ann R Coll Surg Engl 2019; 101(2): 97-102.10.1308/rcsann.2018.0158635187730286659]Search in Google Scholar
[24. Li W, Zhu Q, Lai X et al. Value of preoperative ultrasound-guided fine-needle aspiration for localization in Tc-99m MIBI-negative primary hyperparathyroidism patients. Medicine (Baltimore) 2017; 96(49): e9051.10.1097/MD.0000000000009051572892429245309]Search in Google Scholar
[25. Ketha H, Lasho MA, Algeciras-Schimnich A. Analytical and clinical validation of parathyroid hormone (PTH) measurement in fine-needle aspiration biopsy (FNAB) washings. Clin Biochem 2016; 49(1-2): 16-21.10.1016/j.clinbiochem.2015.09.00626385495]Search in Google Scholar
[26. Kwak JY, Kim EK, Moon HJ, et al. Parathyroid incidentalomas detected on routine ultrasound-directed fine-needle aspiration biopsy in patients referred for thyroid nodules and the role of parathyroid hormone analysis in the samples. Thyroid 2009; 19(7): 743-8.]Search in Google Scholar
[27. Kedarisetty S, Fundakowski C, Ramakrishnan K, Dadparvar S. Clinical value of Tc99m-MIBI SPECT/CT versus 4D-CT or US in management of patients with hyperparathyroidism. Ear Nose Throat J 2019; 98(3): 149-157.10.1177/014556131982866830938239]Search in Google Scholar